BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18295013)

  • 21. Successful treatment with adalimumab in infliximab-resistant Crohn's disease.
    Barthel HR; Gille T; Halbsguth A; Kramer M
    J Gastroenterol Hepatol; 2005 Sep; 20(9):1464-5. PubMed ID: 16105142
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of Crohn's disease].
    Beglinger Ch
    Ther Umsch; 2003 Mar; 60(3):159-63. PubMed ID: 12693319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunosuppressive treatment and Crohn's disease].
    Delwaide J; Louis E; Gast P; Belaiche J
    Rev Med Liege; 1991 Jan; 46(1):22-8. PubMed ID: 2011678
    [No Abstract]   [Full Text] [Related]  

  • 24. Extra-intestinal Hodgkin's lymphoma in a Crohn's disease patient on long-term azathioprine and infliximab therapy.
    Dahhan T; Al Kahtani K; Bakshi N; Abouzied ME; Helmy A
    Trop Gastroenterol; 2010; 31(1):51-3. PubMed ID: 20860231
    [No Abstract]   [Full Text] [Related]  

  • 25. [Standard therapy of Crohn disease. Consensus-based recommendations].
    Hoffmann JC; Zeitz M
    Internist (Berl); 2002 Nov; 43(11):1376, 1379-85. PubMed ID: 12524918
    [No Abstract]   [Full Text] [Related]  

  • 26. Histoplasma epiglottitis in a patient with Crohn's disease maintained on infliximab, prednisone, and azathioprine.
    Abou Zahr A; Saad Aldin E; Yunyongying P
    Int J Infect Dis; 2013 Aug; 17(8):e650-2. PubMed ID: 23769453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New therapeutic option for M. Crohn : SONIC study (study of biologic and immunomodulator naive patients in Crohn's disease)].
    Fölsch UR; Nitschmann S
    Internist (Berl); 2010 Sep; 51(9):1202-4. PubMed ID: 20658120
    [No Abstract]   [Full Text] [Related]  

  • 28. Infliximab and/or azathioprine in the treatment of Crohn's disease-like complications after IPAA.
    Haveran LA; Sehgal R; Poritz LS; McKenna KJ; Stewart DB; Koltun WA
    Dis Colon Rectum; 2011 Jan; 54(1):15-20. PubMed ID: 21160308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Top-down therapy for Crohn's disease: rationale and evidence.
    D'Haens GR
    Acta Clin Belg; 2009; 64(6):540-6. PubMed ID: 20101879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infliximab and azathioprine: bridge or parachute?
    Travis S
    Gastroenterology; 2006 Apr; 130(4):1354-7. PubMed ID: 16618428
    [No Abstract]   [Full Text] [Related]  

  • 31. Risk factors and outcome of acute severe lower gastrointestinal bleeding in Crohn's disease.
    Kim KJ; Han BJ; Yang SK; Na SY; Park SK; Boo SJ; Park SH; Yang DH; Park JH; Jeong KW; Ye BD; Byeon JS; Myung SJ; Kim JH
    Dig Liver Dis; 2012 Sep; 44(9):723-8. PubMed ID: 22497905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [CED therapy with infliximab. Rapid and lasting remission - complete mucosal healing].
    Wedekind S
    MMW Fortschr Med; 2011 Dec; 153(48):54-5. PubMed ID: 22299262
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of 6-mercaptopurine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: pro.
    Hyams JS
    Inflamm Bowel Dis; 2005 Feb; 11(2):197-9. PubMed ID: 15677914
    [No Abstract]   [Full Text] [Related]  

  • 34. Primary biliary cirrhosis developing in a patient with Crohn's disease during the course of infliximab treatment: the first case in the literature.
    Sisman G; Erzin Y; Bal K
    J Crohns Colitis; 2013 Oct; 7(9):e397-8. PubMed ID: 23583098
    [No Abstract]   [Full Text] [Related]  

  • 35. [Crohn's disease--standards of treatment 2004].
    Kruis W
    Praxis (Bern 1994); 2005 Oct; 94(41):1595-8. PubMed ID: 16245637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Evolution of Treatment Paradigms in Crohn's Disease: Beyond Better Drugs.
    Khanna R; Jairath V; Feagan BG
    Gastroenterol Clin North Am; 2017 Sep; 46(3):661-677. PubMed ID: 28838421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mucosal healing with methotrexate in Crohn's disease: a prospective comparative study with azathioprine and infliximab.
    Laharie D; Reffet A; Belleannée G; Chabrun E; Subtil C; Razaire S; Capdepont M; de Lédinghen V
    Aliment Pharmacol Ther; 2011 Mar; 33(6):714-21. PubMed ID: 21235604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
    Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S
    Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longstanding Crohn's vulvitis successfully treated with combined anti-TNFα antibody and azathioprine.
    Macdonagh E; Pugh S; Fox R
    J Obstet Gynaecol; 2013 Jul; 33(5):530. PubMed ID: 23815219
    [No Abstract]   [Full Text] [Related]  

  • 40. Discontinuation of infliximab in patients with Crohn's disease on combination therapy.
    Hindson J
    Nat Rev Gastroenterol Hepatol; 2023 Mar; 20(3):131. PubMed ID: 36755080
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.